Publication
German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients
Journal Paper/Review - Aug 1, 2017
Möbus V, Thomssen C, Untch M, Nekljudova V, Loibl S, du Bois A, Bauerfeind I, Müller V, Huober Jens, Fehm T, Conrad B, Harbeck N, Elling D, Tesch H, Schneeweiss A, Lück H-J, Jackisch C, von Minckwitz G, German Breast Group (GBG), the AGO Breast Study Group (AGO-B) and NOGGO Study Groups
Möbus, V
9
0
von Minckwitz, G
14
0
Jackisch, C
17
0
Lück, H-J
3
0
Schneeweiss, A
14
0
Tesch, H
9
0
Elling, D
1
0
Harbeck, N
15
0
Conrad, B
2
0
Fehm, T
8
0
Huober, Jens
chief physicianBrustzentrum St.Gallen, Medizinische Onkologie und Hämatologie · Dept. IV, Dept. I
297
12
Müller, V
7
0
Bauerfeind, I
3
0
du Bois, A
10
0
Loibl, S
30
0
Nekljudova, V
4
0
Untch, M
19
0
Thomssen, C
10
0
German Breast Group (GBG), the AGO Breast Study Group (AGO-B) and NOGGO Study Groups,
1
0